Biotage Public Offer by KKR
Deal News | Apr 22, 2025 | Simpson Thacher & Bartlett
Simpson Thacher & Bartlett is advising affiliates of the private equity firm KKR in connection with a recommended public offer to the shareholders of Biotage AB to tender all of their ordinary shares. Listed on Nasdaq Stockholm, Biotage is valued at approximately SEK 11.6 billion under this offer. The completion of this offer is contingent upon obtaining regulatory clearances. Biotage is known for providing innovative and sustainable solutions within its market. The involvement of a prominent law firm like Simpson Thacher underscores the significance of this transaction as KKR seeks to expand its portfolio with Biotage.
Sectors
- Private Equity
- Life Sciences
Geography
- Sweden – Biotage AB, the target company in the transaction, is based in Sweden and listed on Nasdaq Stockholm.
Industry
- Private Equity – KKR, a significant participant in this article, is a major global private equity firm.
- Life Sciences – Biotage is a provider of innovative and sustainable solutions in the Life Sciences sector.
Financials
- SEK 11,607 million – The valuation of Biotage under the KKR public offer.
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| Simpson Thacher & Bartlett | Legal Advisor | Company | A law firm representing KKR in the public offer for Biotage. |
| KKR | Bidding Company | Company | A leading global private equity firm making a public offer for Biotage. |
| Biotage AB | Target Company | Company | A Swedish company providing innovative and sustainable solutions. |